Notices of Funding Opportunities (NOFOs)
| Title | Announcement Number | Opening Date | Expiration Date | Activity Code |
|---|---|---|---|---|
| Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed) | RFA-RM-27-025 | 10/23/2026 | 11/24/2026 | UM1 |
| Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed) | RFA-RM-27-016 | 10/23/2026 | 11/24/2026 | UM1 |
| Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed) | RFA-RM-27-007 | 10/23/2026 | 11/24/2026 | UG3/UH3 |
| Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional) | PAR-28-014 | 01/14/2027 | 10/12/2029 | RP1 |
| Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | RFA-CA-27-021 | 05/21/2026 | 10/20/2026 | U24 |
| Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | RFA-CA-27-020 | 06/01/2026 | 10/20/2026 | U24 |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) | RFA-CA-27-019 | 06/01/2026 | 10/20/2027 | U01 |
| Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) | RFA-CA-27-002 | 06/10/2026 | 11/11/2026 | R33 |
| Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) | RFA-CA-27-001 | 06/10/2026 | 11/11/2026 | R61 |
| INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required) | RFA-OD-27-005 | 09/15/2026 | 06/16/2028 | R61/R33 |
| INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed) | RFA-OD-27-004 | 09/15/2026 | 06/16/2028 | R01 |
| INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed) | RFA-OD-27-003 | 09/15/2026 | 06/16/2028 | R21 |
| Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) | PAR-27-072 | 09/05/2026 | 07/06/2029 | R01 |
| The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) | PAR-26-134 | 05/05/2026 | 11/06/2028 | U01 |
| Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) | PAR-25-243 | 01/05/2025 | 01/08/2028 | R01 |
| Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) | PAR-25-244 | 01/16/2025 | 11/17/2027 | R21 |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) | PAR-25-044 | 01/16/2025 | 01/08/2028 | R21 |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) | PAR-25-043 | 01/05/2025 | 01/08/2028 | R01 |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | 11/04/2024 | 12/05/2026 | R50 |
| Support for Research Excellence – First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) | PAR-25-415 | 08/09/2025 | 09/08/2028 | R16 |
| Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) | PAR-25-414 | 08/29/2025 | 09/08/2028 | R16 |
| Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) | PAR-24-311 | 01/05/2025 | 01/08/2028 | R01 |
DCB-Supported NIH Highlighted Topics
NIH Highlighted Topics inform the research community about particular areas of science of interest to NIH. Below are some of DCB's latest scientific interests:
- Accelerating Research in Celiac Disease
- Advanced Biomaterials for Biomedical Research
- Advancing Autoimmune Disease Research: Integrating Genetic, Environmental, and Immunological Factors to Improve Diagnosis and Treatment
- Advancing Childhood and Adolescent & Young Adult (AYA) Cancer Research
- Advancing Microbiome Science Through Multidisciplinary Mechanistic Investigations of the Human Microbiome in Health and Disease
- Advancing Precision Research for Lung Cancer in Never Smokers and Its Risk Factors
- Building Health through Multidomain Resilience Research from Molecules to Communities: Mechanisms, Measures, and Biomarkers
- Cancer and Alzheimer’s Disease Intersection (CADIC)
- Immune Mechanisms for Disease Prevention
- Quantum Information Science & Technologies for Biomedical Applications
- Research on the Role of Post-Translational Modifications in Human Health and Disease